rs34963246

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_015404.4(WHRN):​c.2283C>T​(p.Ser761Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0926 in 1,613,262 control chromosomes in the GnomAD database, including 8,045 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1261 hom., cov: 33)
Exomes 𝑓: 0.090 ( 6784 hom. )

Consequence

WHRN
NM_015404.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.750

Publications

7 publications found
Variant links:
Genes affected
WHRN (HGNC:16361): (whirlin) This gene is thought to function in the organization and stabilization of sterocilia elongation and actin cystoskeletal assembly, based on studies of the related mouse gene. Mutations in this gene have been associated with autosomal recessive non-syndromic deafness and Usher Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
WHRN Gene-Disease associations (from GenCC):
  • Usher syndrome type 2D
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • autosomal recessive nonsyndromic hearing loss 31
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 9-114404031-G-A is Benign according to our data. Variant chr9-114404031-G-A is described in ClinVar as Benign. ClinVar VariationId is 45669.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.75 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015404.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WHRN
NM_015404.4
MANE Select
c.2283C>Tp.Ser761Ser
synonymous
Exon 10 of 12NP_056219.3
WHRN
NM_001173425.2
c.2280C>Tp.Ser760Ser
synonymous
Exon 10 of 12NP_001166896.1
WHRN
NM_001346890.1
c.1230C>Tp.Ser410Ser
synonymous
Exon 6 of 8NP_001333819.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WHRN
ENST00000362057.4
TSL:1 MANE Select
c.2283C>Tp.Ser761Ser
synonymous
Exon 10 of 12ENSP00000354623.3
WHRN
ENST00000265134.10
TSL:1
c.1134C>Tp.Ser378Ser
synonymous
Exon 10 of 12ENSP00000265134.6
WHRN
ENST00000674036.9
c.2073C>Tp.Ser691Ser
synonymous
Exon 9 of 11ENSP00000501297.5

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17718
AN:
152186
Hom.:
1256
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.192
Gnomad AMI
AF:
0.0374
Gnomad AMR
AF:
0.129
Gnomad ASJ
AF:
0.0346
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0253
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0907
Gnomad OTH
AF:
0.0889
GnomAD2 exomes
AF:
0.0914
AC:
22906
AN:
250592
AF XY:
0.0843
show subpopulations
Gnomad AFR exome
AF:
0.197
Gnomad AMR exome
AF:
0.150
Gnomad ASJ exome
AF:
0.0365
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.112
Gnomad NFE exome
AF:
0.0928
Gnomad OTH exome
AF:
0.0813
GnomAD4 exome
AF:
0.0901
AC:
131660
AN:
1460958
Hom.:
6784
Cov.:
37
AF XY:
0.0864
AC XY:
62761
AN XY:
726752
show subpopulations
African (AFR)
AF:
0.202
AC:
6749
AN:
33474
American (AMR)
AF:
0.148
AC:
6599
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0359
AC:
937
AN:
26136
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39700
South Asian (SAS)
AF:
0.0254
AC:
2194
AN:
86256
European-Finnish (FIN)
AF:
0.118
AC:
6212
AN:
52570
Middle Eastern (MID)
AF:
0.0246
AC:
142
AN:
5768
European-Non Finnish (NFE)
AF:
0.0932
AC:
103675
AN:
1111950
Other (OTH)
AF:
0.0851
AC:
5141
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
7664
15328
22992
30656
38320
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3870
7740
11610
15480
19350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.116
AC:
17738
AN:
152304
Hom.:
1261
Cov.:
33
AF XY:
0.115
AC XY:
8551
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.192
AC:
7974
AN:
41570
American (AMR)
AF:
0.130
AC:
1983
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0346
AC:
120
AN:
3468
East Asian (EAS)
AF:
0.000964
AC:
5
AN:
5186
South Asian (SAS)
AF:
0.0245
AC:
118
AN:
4822
European-Finnish (FIN)
AF:
0.107
AC:
1139
AN:
10616
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0908
AC:
6174
AN:
68028
Other (OTH)
AF:
0.0880
AC:
186
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
802
1604
2406
3208
4010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0983
Hom.:
422
Bravo
AF:
0.123
Asia WGS
AF:
0.0270
AC:
94
AN:
3478
EpiCase
AF:
0.0803
EpiControl
AF:
0.0805

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Jun 19, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive nonsyndromic hearing loss 31 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Usher syndrome type 2D Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
3.7
DANN
Benign
0.73
PhyloP100
-0.75
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34963246; hg19: chr9-117166311; COSMIC: COSV54335995; API